Artificial Intelligence in Histopathological Analysis for Predicting Immunotherapy Response in Cutaneous Melanoma

Seungah Yoo1, Ji Hyun Lee1

  • 1Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Summary

Artificial intelligence (AI) enhances melanoma prognosis by automating tumor-infiltrating lymphocyte (TIL) analysis. AI-powered spatial profiling of TILs improves prediction of immunotherapy response, offering a more objective and comprehensive approach.